Polaris Partners

Develops novel therapeutics for glaucoma and retinal diseases

Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers

Develops precision immunoregulatory medicines based on tissue Treg biology

Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...